Rare diseases
Investigational molecules
Locations
Back to Germany325 clinical trials in Goettingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination
GermanyGermanyStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
GermanyLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
GermanyStudy of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer
GermanyStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
GermanyStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
GermanyStudy on the Effectiveness of Oxaliplatin or Gemcitabine Chemotherapy in Patients with Resected Pancreatic Cancer Using Standard or Genetic Allocation Methods
GermanyStudy on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
GermanyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
GermanyStudy on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation
GermanyStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials in Göttingen are exploring cardiovascular diseases and acute ischemic stroke, with a focus on improving outcomes in people at high risk of serious events.
These studies aim to support better prevention, emergency treatment, and long-term protection against major vascular complications.
A strong group of trials in Göttingen is centered on breast cancer, colorectal cancer, and selected pediatric and head and neck tumors, reflecting active work in oncology.
Researchers are also studying treatment response in advanced and recurrent disease, helping refine care for both adults and children.
Trials in nervous system diseases are examining both stroke recovery and chronic neurological conditions, including diseases that affect movement and cognition.
This area includes work on diagnostic value, symptom relief, and longer-term safety in progressive neurologic disorders.
Research on eye diseases is addressing conditions that can gradually affect vision, especially disorders linked to aging and inflammation.
These studies are focused on protecting visual function and finding better ways to manage chronic retinal disease.
Trials in immune system diseases are looking at allergy-related conditions and immune-mediated disorders that can affect quality of life and daily functioning.
The research includes both treatment-focused studies and efforts to improve everyday symptom management.
In the area of respiratory tract diseases, investigators are studying common upper-airway illness as well as breathing outcomes in very premature infants.
These trials aim to make care more effective for both short-term infection symptoms and early-life lung health.
Research in hemic and lymphatic diseases is centered on childhood blood cancers, with attention to outcomes and treatment response in difficult-to-treat settings.
These studies reflect an effort to refine pediatric oncology care while maintaining strong safety and effectiveness standards.
Trials in digestive system diseases include supportive care for treatment-related bowel injury and painful inflammatory episodes.
The studies are aimed at improving quality of life for patients dealing with gastrointestinal and inflammatory symptoms.
Work in male urogenital diseases includes research on complications associated with treatment for prostate cancer, especially bowel side effects after radiation.
These trials focus on easing treatment burden and improving patient comfort during recovery.
Several studies are investigating musculoskeletal diseases and related muscle disorders that affect strength, movement, and daily activity.
This research area includes efforts to make symptom control more consistent for chronic neuromuscular conditions.
Clinical research in psychiatry and psychology is represented mainly through studies of cognitive decline and early dementia, where mental function and daily independence are key concerns.
These trials are designed to better understand disease progression and strengthen care options for patients and families.
Studies in otorhinolaryngologic diseases are addressing upper-airway and throat complaints, with an emphasis on easing bothersome symptoms.
This line of research aims to improve comfort and day-to-day function for patients with frequent ENT problems.
Some trials bridge eye disease and immune-mediated inflammation, especially where swelling or tissue damage can threaten vision.
These studies are focused on slowing progression and improving long-term eye health.
Some clinical trials in Göttingen span more than one therapeutic area, bringing together cardiovascular, neurological, oncology, and rare disease research under broader care questions.
This mix highlights a broad and active research environment with multiple specialties contributing to patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
